SEC Company Response from Avidity Biosciences, Inc. (RNA) (CIK 0001599901) (RNA) — Jun 9, 2020
Avidity Biosciences, Inc. (RNA) (CIK 0001599901)
Date: June 9, 2020 · CIK: 0001599901 · Accession: 0001193125-20-164628
AI Filing Summary & Sentiment
File numbers found in text: 333-238612
Letter
Re: Avidity Biosciences, Inc.
June 9, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Ada D. Sarmento
Registration Statement on Form S-1 (File No. 333-238612)
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), we wish to advise that between June 8, 2020 and the date hereof, approximately 3,700 copies of the Preliminary Prospectus, dated June 8, 2020, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement be accelerated to 4:00 p.m. Eastern Time, on Thursday, June 11, 2020 or as soon thereafter as practicable.
[signature page follows]
Very truly yours,
COWEN AND COMPANY, LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP June 9, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Ada D. Sarmento Re: Avidity Biosciences, Inc. Registration Statement on Form S-1 (File No. 333-238612) Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), we wish to advise that between June 8, 2020 and the date hereof, approximately 3,700 copies of the Preliminary Prospectus, dated June 8, 2020, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement. We wish to advise you that the participating underwriters have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement be accelerated to 4:00 p.m. Eastern Time, on Thursday, June 11, 2020 or as soon thereafter as practicable. [signature page follows] Very truly yours, COWEN AND COMPANY, LLC SVB LEERINK LLC CREDIT SUISSE SECURITIES (USA) LLC WELLS FARGO SECURITIES, LLC As representatives of the Underwriters COWEN AND COMPANY, LLC By: /s/ Tanya Joseph Name: Tanya Joseph Title: Managing Director SVB LEERINK LLC By: /s/ Daniel Dubin Name: Daniel Dubin Title: Vice Chairman CREDIT SUISSE SECURITIES (USA) LLC By: /s/ John Hoffman Name: John Hoffman Title: Managing Director, ECM WELLS FARGO SECURITIES, LLC By: /s/ Geoffrey Goodman Name: Geoffrey Goodman Title: Managing Director [Signature Page to Acceleration Request Letter]